EnWave Sells Second Radiant Energy Vacuum Machine to the United States Army
April 30 2019 - 9:00AM
EnWave Corporation (TSX-V: ENW | FSE:E4U) (“EnWave”, or the
"Company") announced today that it has signed a Purchase
Requisition (the "Agreement") with the United States Army Combat
Capabilities Development Command Soldier Center to supply a second
Radiant Energy Vacuum (“REV™”) machine to help further the
development efforts focused on improving the quality of Close
Combat Assault Rations and their subsequent deployment.
After a successful presentation at the Pentagon
in May 2018 and confirmed internal demand for REV™ dried rations,
the CCDC Soldier Center purchased their first REV™ machine and fast
tracked the research and development necessary for implementation
with close combat warfighters. Since that time, the CCDC Soldier
Center has made significant product development progress in several
areas and has also begun collaborating with the U.S. Army’s
approved supplier network.
EnWave and the CCDC Soldier Center will continue
to collaborate with potential vendors to manufacture and supply
REV™-dried, nutrient rich field rations for the United States Army.
Any interested parties are encouraged to contact EnWave Corporation
at info@enwave.net.
About the U.S Army
Combat Capabilities Development Command Soldier Center
(CCDC-SC)
Formerly known as the U.S. Army Natick Soldier Research,
Development and Engineering Center (NSRDEC), the U.S Army Combat
Capabilities Development Command Soldier Center optimizes and
modernizes individual Soldier and squad performance, and increases
combat readiness and lethality to ensure dominance in multi-domain
operations. CCDC Soldier Center uses science and engineering
expertise, in collaboration with our DoD, industry and academia
partners in the innovation ecosystem, to advance Soldier/squad
performance optimization, readiness, lethality, and synthetic
training environments. The CCDC Soldier Center’s research and
development focus is concentrated on six core domains, each of
which provide exactly what the Soldier needs given the unique
combat environment in which they serve. These include: Basic &
Early Applied Research; Clothing & Protective Equipment;
Airdrop/Aerial Delivery; DoD Combat Feeding; Expeditionary Maneuver
Support; Soldier/Small Combat Unit Technology Maturation &
Demonstration; Human Systems Integration Sciences; and DoD Combat
Feeding. These Soldier Center ensures our Soldiers are optimized,
protected, and lethal.
About EnWave EnWave
Corporation, a Vancouver-based advanced technology company, has
developed Radiant Energy Vacuum (“REV™”) – an innovative,
proprietary method for the precise dehydration of organic
materials. EnWave has further developed patent-pending methods for
uniformly drying and decontaminating cannabis through the use of
REV™ technology, shortening the time from harvest to marketable
cannabis products.
REV™ technology’s commercial viability has been
demonstrated and is growing rapidly across several market verticals
in the food, and pharmaceutical sectors including legal cannabis.
EnWave’s strategy is to sign royalty-bearing commercial licenses
with industry leaders in multiple verticals for the use of REV™
technology. The company has signed over twenty royalty-bearing
licenses to date, opening up nine distinct market sectors for
commercialization of new and innovative products. In addition to
these licenses, EnWave has formed a Limited Liability Corporation,
NutraDried Food Company, LLC, to develop, manufacture, market and
sell all-natural cheese snack products in the United States under
the Moon Cheese® brand.
EnWave has introduced REV™ as the new
dehydration standard in the food and biological material sectors:
faster and cheaper than freeze drying, with better end product
quality than air drying or spray drying. EnWave currently has three
commercial REV™ platforms:
- nutraREV® which is used in the food industry to dry food
products quickly and at low-cost, while maintaining high levels of
nutrition, taste, texture and colour;
- powderREV® which is used for the bulk dehydration of food
cultures, probiotics and fine biochemicals such as enzymes below
the freezing point, and
- quantaREV® which is used for continuous, high-volume
low-temperature drying.
An additional platform, freezeREV®, is being
developed as a new method to stabilize and dehydrate
biopharmaceuticals such as vaccines and antibodies. More
information about EnWave is available at www.enwave.net.
EnWave CorporationMr. Brent
Charleton, CFAPresident & CEO
For further information:
Brent Charleton, CFA , President & CEO at +1 (778) 378-9616
E-mail: bcharleton@enwave.net
John P.A. Budreski, Executive Chairman at +1 (416)
930-0914E-mail: jbudreski@enwave.net
Deborah Honig, Corporate Development, Adelaide Capital Markets
at + 1 (647) 203-8793E-mail: dhonig@enwave.net
Safe Harbour for Forward-Looking Information
Statements: This press release may contain forward-looking
information based on management's expectations, estimates and
projections. All statements that address expectations or
projections about the future, including statements about the
Company's strategy for growth, product development, market
position, expected expenditures, and the expected synergies
following the closing are forward-looking statements. All third
party claims referred to in this release are not guaranteed to be
accurate. All third party references to market information in this
release are not guaranteed to be accurate as the Company did not
conduct the original primary research. These statements are not a
guarantee of future performance and involve a number of risks,
uncertainties and assumptions. Although the Company has attempted
to identify important factors that could cause actual results to
differ materially, there may be other factors that cause results
not to be as anticipated, estimated or intended. There can be no
assurance that such statements will prove to be accurate, as actual
results and future events could differ materially from those
anticipated in such statements. Accordingly, readers should not
place undue reliance on forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
EnWave (TSXV:ENW)
Historical Stock Chart
From Apr 2024 to May 2024
EnWave (TSXV:ENW)
Historical Stock Chart
From May 2023 to May 2024